الفهرس 
Prevalence of hepatitis C virus among psoriatic patients
AbstractOnly 14 pages are availabe for public view
 |  | from | 205 |  |  |
| | | from | 205 | | |
Abstract
Psoriasis is a common chronic immune - mediated skin disease. Its prevalence is estimated to be anywhere from 0.6 to 4.8%. Hepatitis C is a serious public health problem all over the world with a global prevalence of 3%; Egypt has the highest HCV prevalence in the world. Studies have reported high prevalence of hepatitis C infection (HCV) among patients with psoriasis. To estimate the prevalence of HCV infection among psoriatic patients and to define the underlying risk factors for the occurrence of HCV infection among psoriatic patients. One hundred psoriatic patients recruited from the dermatology outpatient clinic, Kasr Alaini, Faculty of Medicine. And 200 healthy volunteers collected from blood bank of Kasr Alaini hospital as blood donors. Estimation of liver functions, anti HCV antibody (HCV - Ab) was done to all patients and control. Qualitative HCV RNA by PCR analysis was performed for those who were HCV - Ab positive